Clinical Trial Update: A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH [Phase 2]

View source ↗

Summary

Phase 2b trial evaluating the efficacy and safety of tildacerfont in adults with congenital adrenal hyperplasia was terminated. Results for the study were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Drugs mentioned

• Tildacerfont (tildacerfont)

Snippet

Sponsor: Spruce Biosciences | Conditions: Congenital Adrenal Hyperplasia | Phase 2 | Status: TERMINATED | Results posted: 2025-07-08